GlassBury AI combines agentic patient matching with culturally sensitive community education to eliminate healthcare disparities. By pairing AI with expert-curated workshops, we build the trust necessary to connect underrepresented patients with life-changing clinical trials.
Tiny Bubbles, Big Breakthrough: How Exosomes Carry Alzheimer's Treatments Past the Blood–Brain Barrier
Your brain consumes roughly 20% of your body's energy, meaning it relies on a massive network of blood vessels. To protect your central nervous system from harmful chemical swings and infections, the cells lining these blood vessels fit together like microscopic puzzle pieces sealed with airtight biological glue. This tight network is the Blood–Brain Barrier.
Estrogen Receptor ERβ: A New Hope in the Fight Against Alzheimer’s in Women
If you look at the statistics for Alzheimer’s disease, one striking detail immediately stands out: almost two-thirds of all people living with Alzheimer's are women. For decades, scientists and doctors explained this gap simply by pointing to the calendar—women
The Role of AI in Therapeutic Drug Research and Development: Benefits and Challenges
Artificial intelligence (AI) has emerged as a transformative technology across various sectors, and its potential impact on therapeutic drug research and development is significant. By leveraging AI algorithms and machine learning, researchers can potentially accelerate the drug discovery process, identify promising drug candidates, and optimize treatment strategies. However, the integration of AI
Ethical Integrity in Clinical Research: From Historical Breaches to AI's Future Frontier
Delve into the evolution of ethical standards in clinical research, exploring the profound impact of past violations and confronting the complex challenges poised by modern advancements. This elaborate description illuminates how historical breaches have indelibly shaped current bioethical frameworks, while critically examining the emerging ethical dilemmas, particularly those at AI's future frontier.
AI-Designed Oral GLP-1RA Shows Promise in Weight Loss
In the ongoing global health challenge of obesity and its associated conditions, the search for effective and convenient treatments is paramount. Recently, a significant breakthrough has emerged from China-based MindRank, a biotech company that has reported promising results from its Phase IIb clinical trial for an oral medication known as MDR-001.
Lung Cancer's New Friend: Why AI Is the Ultimate Partner
Discover how Artificial Intelligence (AI) is revolutionizing lung cancer care, from early detection and accurate diagnosis to personalized treatment decisions and prognosis prediction. AI systems enhance the reading of low-dose CT (LDCT) and chest X-rays (CXR), significantly improving nodule detection accuracy and reducing radiologist workload. Explore AI's role in analyzing whole slide imaging (WSI) for histopathological insights and predicting molecular features like gene mutations and PD-L1 expression. This comprehensive approach, integrating radiomics, genomics, and clinical data, holds promise for optimizing lung cancer screening, diagnosis, and patient outcomes in the future.
AI and Mental Health: A New Era of Care
Mental health is a vital part of our overall well-being, yet it's often shrouded in stigma and faces numerous challenges in terms of diagnosis and treatment.